Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClarkson Regulatory News (CKN)

Share Price Information for Clarkson (CKN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,240.00
Bid: 4,230.00
Ask: 4,245.00
Change: 30.00 (0.71%)
Spread: 15.00 (0.355%)
Open: 4,220.00
High: 4,270.00
Low: 4,200.00
Prev. Close: 4,210.00
CKN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Acquisition

2 Feb 2015 07:00

RNS Number : 7220D
Clarkson PLC
02 February 2015
 



This announcement and the information contained herein is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or from australia, canada, Japan, the republic of south africa, the united states or any other jurisdiction in which the same would be unlawful. please see the important notice at the end of this announcement.

 

CLARKSON PLC

 

Completion of the Acquisition of RS PLATOU ASA, Re-Admission and total voting rights

 

2 February 2015

 

Further to the announcement on 28 January 2015, Clarkson PLC ("Clarksons") is pleased to announce that completion of its acquisition of RS Platou ASA took place today.

 

Pursuant to paragraph 5.6.19G of the Listing Rules, the premium listing of Clarksons' Existing Ordinary Shares on the Official List will at 8am this morning be cancelled and the Existing Ordinary Shares immediately re-admitted and the Consideration Shares immediately admitted to the premium listing segment of the Official List and trading on the London Stock Exchange's main market for listed securities.

 

As described in the prospectus published by the Company on 17 December 2014 (the "Prospectus"), the appointments of Peter M. Anker and Birger Nergaard to the board of directors of Clarksons have now taken effect.

 

Andi Case, Chief Executive of Clarksons, commented:

 

"I am delighted to announce the completion of the acquisition of RS Platou ASA and we look forward to welcoming the Platou team into the enlarged group. The priority now is to implement our integration plans and we are excited about the enhanced offering we will be able to provide our clients following the combination of the two businesses".

Following Re-Admission, the number of ordinary shares that Clarksons has in issue is 30,116,758, and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in Clarksons, under the Disclosure and Transparency Rules.

Capitalised terms used in this announcement shall have the meanings as set out in the Prospectus.

 

For further information contact:

 

Clarkson PLC

+44 207 334 0000

Andi Case

Jeff Woyda

Nomura International plc

+44 207 102 1000

Andrew McNaught

Andrew Forrester

Nicholas Marren

Panmure Gordon (UK) Limited

+44 207 886 2500

Richard Gray

Andrew Potts

Tom Salvesen

Hudson Sandler

+44 207 796 4133

Andrew Nicolls

 

IMPORTANT NOTICE

This Announcement and the information contained in it is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or from the United States (including its territories and possessions, any state of the United States and the District of Columbia, collectively the "United States") Australia, Canada, Japan or the Republic of South Africa or any other state or jurisdiction in which the same would be restricted, unlawful or unauthorised (each a "Restricted Territory"). This Announcement is for information purposes only and does not constitute an offer to sell or issue or the solicitation of an offer to buy, acquire or subscribe for shares in the capital of the Company in any Restricted Territory or to any person to whom it is unlawful to make such offer or solicitation. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions. Subject to certain exemptions, the securities referred to herein may not be offered or sold in any Restricted Territory or for the account or benefit of any national resident or citizen of any Restricted Territory.

This Announcement and the information contained herein is not an offer of securities for sale in the United States and there will be no public offer of securities in the United States. The securities discussed herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities laws or with any securities regulatory authority of any other state or other jurisdiction of the United States, and may not be offered, sold or transferred, directly or indirectly, in the United States absent registration under the Securities Act or an available exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any other state or jurisdiction of the United States.

This Announcement has been issued by, and is the sole responsibility of the Company. No representation or warranty express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Nomura International plc ("Nomura") or Panmure Gordon (UK) Limited ("Panmure Gordon") or by any of their respective affiliates or agents as to or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

Nomura, which is authorised by the Prudential Regulation Authority and is regulated by the Financial Conduct Authority in the United Kingdom, is acting solely for the Company in relation to the Acquisition and nobody else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice in relation to the Acquisition or any other matter referred to in this Announcement. Apart from the responsibilities and liabilities, if any, which may be imposed on Nomura by the Financial Services and Markets Act 2000 or by the regulatory regime established under it, neither Nomura nor any of its respective affiliates accepts any responsibility whatsoever for the contents of the information contained in this Announcement or for any other statement made or purported to be made by or on behalf of Nomura or any of its respective affiliates in connection with the Company or the Acquisition. Nomura and its respective affiliates accordingly disclaim all and any liability, whether arising in tort, contract or otherwise (save as referred to above) in respect of any statements or other information contained in this Announcement and no representation or warranty, express or implied, is made by Nomura or any of its respective affiliates as to the accuracy, fairness, verification, completeness or sufficiency of the information contained in this Announcement. Nothing in this Announcement is, or shall be relied upon as, a promise or representation in this respect, whether as to the past or the future.

Panmure Gordon, which is regulated by the Financial Conduct Authority in the United Kingdom, is acting solely for the Company and nobody else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice in relation to any matter referred to in this Announcement. Apart from the responsibilities and liabilities, if any, which may be imposed on Panmure Gordon by the Financial Services and Markets Act 2000 or by the regulatory regime established under it, neither Panmure Gordon nor any of its respective affiliates accepts any responsibility whatsoever for the contents of the information contained in this Announcement or for any other statement made or purported to be made by or on behalf of Panmure Gordon or any of its respective affiliates in connection with the Company. Panmure Gordon and its respective affiliates accordingly disclaim all and any liability, whether arising in tort, contract or otherwise (save as referred to above) in respect of any statements or other information contained in this Announcement and no representation or warranty, express or implied, is made by Panmure Gordon or any of its respective affiliates as to the accuracy, fairness, verification, completeness or sufficiency of the information contained in this Announcement. Nothing in this Announcement is, or shall be relied upon as a promise or representation in this respect, whether as to the past or the future.

This Announcement does not constitute or form part of, and should not be construed as, an offer, solicitation or invitation to subscribe, for, underwrite or otherwise acquire, any securities of the Company or any member of its group in any jurisdiction or an inducement to enter into investment activity.

The information in this Announcement may not be forwarded or distributed to any other person and may not be reproduced in any manner whatsoever. Any forwarding, distribution, reproduction, or disclosure of this information in whole or in part is unauthorised. Failure to comply with this directive may result in a violation of the Securities Act or the applicable laws of other jurisdictions.

The information contained in this Announcement is subject to change without notice and, except as required by applicable law, the Company does not assume any responsibility or obligation to update publicly or review any of the forward-looking statements contained herein. You should not place undue reliance on forward-looking statements, which speak only as of the date of this Announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFMGGZVZGGKZG
Date   Source Headline
6th Dec 20223:00 pmRNSHolding(s) in Company
1st Dec 20229:30 amRNSTotal Voting Rights
18th Nov 20224:00 pmRNSHolding(s) in Company
15th Nov 20223:00 pmRNSHolding(s) in Company
1st Nov 202211:00 amRNSTotal Voting Rights
27th Oct 20225:15 pmRNSBlock listing Interim Review
4th Oct 202210:00 amRNSDirector/PDMR Shareholding
23rd Sep 20229:00 amRNSAdditional Listing
1st Sep 202211:30 amRNSTotal Voting Rights
12th Aug 20227:00 amRNSDirectorate Change
8th Aug 20227:00 amRNSInterim results
13th Jul 20227:00 amRNSTrading Update
1st Jun 202211:30 amRNSTotal Voting Rights
18th May 20222:00 pmRNSDirector/PDMR Shareholding
17th May 20222:00 pmRNSHolding(s) in Company
11th May 20225:00 pmRNSResult of AGM
11th May 202212:00 pmRNSTrading Statement at AGM
3rd May 20221:30 pmRNSTotal Voting Rights
26th Apr 20221:00 pmRNSBlock listing Interim Review
20th Apr 20225:30 pmRNSDirector/PDMR Shareholding
6th Apr 20225:36 pmRNSAnnual Report and Notice of AGM
1st Apr 20221:00 pmRNSTotal Voting Rights
23rd Mar 20225:00 pmRNSDirector/PDMR Shareholding
15th Mar 20226:00 pmRNSHolding(s) in Company
8th Mar 202211:00 amRNSHolding(s) in Company
7th Mar 20227:00 amRNSFinal Results
2nd Mar 20227:00 amRNSAppointment of New Chair
15th Feb 20226:00 pmRNSHolding(s) in Company
10th Feb 20226:10 pmRNSHolding(s) in Company
1st Feb 20222:00 pmRNSTotal Voting Rights
7th Jan 20227:00 amRNSClosed Period Trading Update
4th Jan 20224:00 pmRNSTotal Voting Rights
15th Dec 20217:00 amRNSDirectorate Change
6th Dec 20217:00 amRNSTrading Update
2nd Dec 202110:30 amRNSHolding(s) in Company
1st Dec 20212:00 pmRNSTotal Voting Rights
26th Oct 20211:00 pmRNSBlock listing Interim Review
1st Oct 20214:00 pmRNSDirector/PDMR Shareholding
1st Oct 202110:08 amRNSTotal Voting Rights
22nd Sep 20219:00 amRNSAdditional Listing
12th Aug 20213:04 pmRNSDirector/PDMR Shareholding
9th Aug 20217:00 amRNSInterim results
1st Jul 20213:00 pmRNSTotal Voting Rights
5th May 20216:00 pmRNSResult of AGM
5th May 202111:30 amRNSTrading Statement at AGM
4th May 20212:00 pmRNSTotal Voting Rights
27th Apr 20213:00 pmRNSDirector/PDMR Shareholding
26th Apr 20215:00 pmRNSBlock listing Interim Review
20th Apr 20212:08 pmRNSDirector/PDMR Shareholding
14th Apr 20215:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.